immune system
N |
• immunoblot analysis of lysates of homozygous mutant mouse embryonic fibroblasts (MEFs) using antibody to IkappaB demonstrates normal degradation by these cells of IkappaB in response to interleukin 1 (IL-1)
|
• peritoneal macrophages from homozygous mice exhibit diminished type 1 interferon secretion in response to resiquimod, a TLR7-activating ligand
• peritoneal macrophages from homozygous mice exhibit diminished type 1 interferon secretion in response to unmethylated CpG DNA, a TLR9-activating ligand
• immunoblot analysis of lysates of homozygous mutant peritoneal macrophages using antibodies to phosphorylated proteins demonstrates failure of these cells to phosphorylate/activate Ikappa B, JUN N-terminal kinase (JNK) or extracellular signal-related kinase (ERK) in response to the TLR7-activating ligand resiquimod
• immunoblot analysis of lysates of homozygous mutant peritoneal macrophages using antibodies to phosphorylated proteins demonstrates failure of these cells to phosphorylate/activate Ikappa B, JUN N-terminal kinase (JNK) or extracellular signal-related kinase (ERK) in response to the TLR1/TLR2-activating lipopeptide PAM3CSK4
|
hematopoietic system
• peritoneal macrophages from homozygous mice exhibit diminished type 1 interferon secretion in response to resiquimod, a TLR7-activating ligand
• peritoneal macrophages from homozygous mice exhibit diminished type 1 interferon secretion in response to unmethylated CpG DNA, a TLR9-activating ligand
• immunoblot analysis of lysates of homozygous mutant peritoneal macrophages using antibodies to phosphorylated proteins demonstrates failure of these cells to phosphorylate/activate Ikappa B, JUN N-terminal kinase (JNK) or extracellular signal-related kinase (ERK) in response to the TLR7-activating ligand resiquimod
• immunoblot analysis of lysates of homozygous mutant peritoneal macrophages using antibodies to phosphorylated proteins demonstrates failure of these cells to phosphorylate/activate Ikappa B, JUN N-terminal kinase (JNK) or extracellular signal-related kinase (ERK) in response to the TLR1/TLR2-activating lipopeptide PAM3CSK4
|